Protein Summary
Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Plays also a role in meiosis and more particularly in spermatogenesis. Has redundant cellular functions with AURKB and can rescue an AURKB knockdown. Like AURKB, AURKC phosphorylates histone H3 at 'Ser-10' and 'Ser-28'. AURKC phosphorylates the CPC complex subunits BIRC5/survivin and INCENP leading to increased AURKC activity. Phosphorylates TACC1, another protein involved in cell division, at 'Ser-228'. This gene encodes a member of the Aurora subfamily of serine/threonine protein kinases. The encoded protein is a chromosomal passenger protein that forms complexes with Aurora-B and inner centromere proteins and may play a role in organizing microtubules ...more
- ENST00000302804
- ENSP00000302898
- ENSG00000105146
- ENST00000415300
- ENSP00000407162
- ENST00000598785
- ENSP00000471830
- AIE2
- AIK3
- AIRK3
- ARK3
- STK13
- AIE2
- AIK3
- ARK3
- AurC
- SPGF5
- STK13
- HEL-S-90
- aurora-C
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
molecular function | 0.94 | ||
cellular component | 0.81 | ||
small molecule | 0.75 | ||
protein domain | 0.73 | ||
tissue | 0.63 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 114.81 (req: < 5)
Gene RIFs: 53 (req: <= 3)
Antibodies: 468 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 114.81 (req: >= 5)
Gene RIFs: 53 (req: > 3)
Antibodies: 468 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 15
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 32
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 1